Paul C.
- Country
- France
- Department
- Hepato-Gastro-Enterology department
Research Overview
- A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
- Phase 2 Randomized, Placebo-Controlled Study of the Efficacy and Safety of Vamifeport in Adults with HFE-Related Hereditary Hemochromatosis
- Efficacy and Safety of Bepirovirsen in Nucleos(t)ide Analogue-Treated Patients with Chronic Hepatitis B: A Phase 3 Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 70 of 202 partner sites.
Specializations
Hepatic Disorders
The investigator specializes in the management and treatment of hepatic encephalopathy, with particular focus on preventing disease progression in patients with liver cirrhosis.
- Liver Disease Complications
- Cirrhosis Management
- Encephalopathy Prevention
Their research interests encompass innovative therapeutic approaches for managing complications in patients with advanced liver disease.
Therapeutic Innovation
The investigator's work centers on evaluating novel pharmaceutical formulations for liver disease management, particularly exploring new delivery systems for established medications.
- Drug Delivery Systems
- Treatment Optimization
- Clinical Outcomes
Their research focuses on improving therapeutic efficacy through advanced drug formulation techniques.
Preventive Medicine
The investigator concentrates on developing strategies to prevent disease decompensation in patients with chronic liver conditions, with emphasis on reducing hospitalization rates.
- Hospital Admission Prevention
- Disease Progression Management
- Quality of Life Enhancement
Their work aims to improve patient outcomes through preventive therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.